Haematologica
(Apr 2022)
Molecular assessment and the current limits of post-transplant prognostication for chronic myelomonocytic leukemia
- Christopher J. Gibson,
- John Koreth
Affiliations
- Christopher J. Gibson
- Division of Hematologic Malignancies, Dana-Farber Cancer Institute 450 Brookline Ave., Boston MA 02215
- John Koreth
- Division of Hematologic Malignancies, Dana-Farber Cancer Institute 450 Brookline Ave., Boston MA 02215
- DOI
-
https://doi.org/10.3324/haematol.2022.280960
- Journal volume & issue
-
Vol. 108,
no. 1
WeChat QR code